Literature DB >> 15615802

Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy.

Oliver Lindner1, Jürgen Vogt, Annett Kammeier, Peter Wielepp, Jens Holzinger, Detlev Baller, Barbara Lamp, Bert Hansky, Reiner Körfer, Dieter Horstkotte, Wolfgang Burchert.   

Abstract

AIMS: We studied the effects of cardiac resynchronization therapy (CRT) on global and regional myocardial oxygen consumption (MVO2) and myocardial blood flow (MBF) in non-ischaemic (NICM) and ischaemic dilated cardiomyopathy (ICM). METHODS AND
RESULTS: Thirty-one NICM and 11 ICM patients, all of them acute responders, were investigated. MVO2 and MBF were obtained by 11C-acetate PET before and after 4 months of CRT. In NICM global MVO2 and MBF did not change during CRT, while the rate pressure product (RPP) normalized MVO2 increased (P=0.03). Before CRT regional MVO2 and MBF were highest in the lateral wall and lowest in the septum. Under therapy, MVO2 and MBF decreased in the lateral wall (P=0.045) and increased in the septum (P=0.045) resulting in a more uniform distribution. In ICM, global MVO2, MBF, and RPP did not change under CRT. Regional MVO2 and MBF showed no significant changes but a similar tendency in the lateral and septal wall to that in NICM.
CONCLUSION: CRT induces changes of MVO2 and MBF on a regional level with a more uniform distribution between the myocardial walls and improved ventricular efficiency in NICM. Based on the investigated parameters, CRT appears to be more effective in NICM than in ICM.

Entities:  

Mesh:

Year:  2004        PMID: 15615802     DOI: 10.1093/eurheartj/ehi046

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

Review 1.  Theoretical models for coronary vascular biomechanics: progress & challenges.

Authors:  Sarah L Waters; Jordi Alastruey; Daniel A Beard; Peter H M Bovendeerd; Peter F Davies; Girija Jayaraman; Oliver E Jensen; Jack Lee; Kim H Parker; Aleksander S Popel; Timothy W Secomb; Maria Siebes; Spencer J Sherwin; Rebecca J Shipley; Nicolas P Smith; Frans N van de Vosse
Journal:  Prog Biophys Mol Biol       Date:  2010-10-30       Impact factor: 3.667

2.  Optimizing cardiac resynchronization therapy to minimize ATP consumption heterogeneity throughout the left ventricle: a simulation analysis using a canine heart failure model.

Authors:  Yuxuan Hu; Viatcheslav Gurev; Jason Constantino; Natalia Trayanova
Journal:  Heart Rhythm       Date:  2014-03-18       Impact factor: 6.343

Review 3.  Cardiac resynchronization: insight from experimental and computational models.

Authors:  R C P Kerckhoffs; J Lumens; K Vernooy; J H Omens; L J Mulligan; T Delhaas; T Arts; A D McCulloch; F W Prinzen
Journal:  Prog Biophys Mol Biol       Date:  2008-03-05       Impact factor: 3.667

Review 4.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

5.  Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.

Authors:  Emirhan Nemutlu; Song Zhang; Yi-Zhou Xu; Andre Terzic; Li Zhong; Petras D Dzeja; Yong-Mei Cha
Journal:  J Card Fail       Date:  2015-04-22       Impact factor: 5.712

Review 6.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

7.  Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function.

Authors:  Simone C S Brandão; Silvana A D Nishioka; Maria C P Giorgi; Ji Chen; Rubens Abe; Martino Martinelli Filho; Viviane T Hotta; Marcelo L Vieira; Ernest V Garcia; José C Meneghetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

8.  Acute improvement of cardiac efficiency measured by 11C-acetate PET after cardiac resynchronization therapy and clinical outcome.

Authors:  Kenji Kitaizumi; Kazushi Yukiiri; Hisashi Masugata; Hiroyuki Takinami; Yasuyoshi Iwado; Takahisa Noma; Naohisa Hosomi; Koji Ohmori; Shoichi Senda; Masakazu Kohno
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-04       Impact factor: 2.357

9.  Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism.

Authors:  E E van der Wall; M J Schalij; A van der Laarse; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-12       Impact factor: 2.357

Review 10.  What is treatment success in cardiac resynchronization therapy?

Authors:  Paul W X Foley; Francisco Leyva; Michael P Frenneaux
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.